Prospective methylation biomarker validation study in lung cancer

肺癌前瞻性甲基化生物标志物验证研究

• 批准号: nhmrc : 1006695
• 负责人: A/Pr Alexander Dobrovic
• 金额: $ 35.23万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/prospective-methylation-biomarker-lung-cancer/109207
• 关键词: Prospective; methylation; biomarker; validation; study

Lung cancer is a major public health burden with increasing incidence every year. Despite advances, the biology of lung cancer associated with its recurrence either local or distant, with non-smoking lung cancer subtypes and asbestos-related lung cancer remains unexplored.

肺癌是一种主要的公共卫生负担，发病率每年都在增加。尽管取得了进展，但肺癌的生物学与其局部或远处复发有关，包括非吸烟肺癌亚型和石棉相关肺癌，仍未被探索。